Effects of bilobalide on γ-aminobutyric acid levels and glutamic acid decarboxylase in mouse brain

European Journal of Pharmacology

Volumn 367, Issue 2-3, 1999, Pages 165-173

  Sasaki, Keiko ^a,b   Hatta, Shinichi ^a   Haga, Masanobu ^b   Ohshika, Hideyo ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

Author keywords

Anticonvulsant activity; Bilobalide; Ginkgo biloba L.; Glutamic acid decarboxylase; Aminobutyric acid

Indexed keywords

4 AMINOBUTYRIC ACID; BILOBALIDE; GLUTAMATE DECARBOXYLASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032970852     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00968-6     Document Type: Article

References (49)

1. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R.-G., Ji F.Y., Kanbara N., Kuzume H., Sanbo M., Yagi T., Obata K. Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. Biochem. Biophys. Res. Commun. 229:1996;891-895.
2. Asada H., Kawamura Y., Maruyama K., Kume H., Ding R.-G., Kanbara N., Kuzume H., Sanbo M., Yagi T., Obata K. Cleft palate and decreased brain γ-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6496-6499.
3. Biggs C.S., Pearce B.R., Fowler L.J., Whitton P.S. The effect of sodium valproate on extracellular GABA and other amino acids in the rat ventral hippocampus: an in vivo microdialysis study. Brain Res. 594:1992;138-142.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Bradford, H.F., Peterson, D.W., 1987. Current views of the pathobiochemistry of epilepsy. In: Baum, H., Gergey, J., Fanburg, B.L. (Eds.), Molecular Aspects of Medicine, Vol. 9. Pergamon, Oxford, pp. 122-124.
6. Braquet P., Esane A., Buisine E., Hosford D., Broquet C., Koltai M. Recent progress in ginkgolide research. Medical Res. Reviews. 11:1991;295-355.
7. Chatterjee, S.S., Gabard, B.L., Jaggy, H.E.W., 1986. Pharmaceutical compositions containing bilobalide for the treatment of neuropathies. US patent no. 4,571,407.
8. de Deyn P.P., Macdonald R.L. Effects of antiepileptic drugs on GABA responses and reduction of GABA responses by PTZ and DMCM on mouse neurons in cell culture. Epilepsia. 30:1989;17-25.
9. de Deyn P.P., Marescau B., MacDonald R.L. Epilepsy and the GABA-hypothesis a brief review and some examples. Acta Neurologica Belgica. 90:1990;65-81.
10. DeFeudis, F.V., 1991. Pharmacological activities and clinical applications. In: DeFeudis, F.V. (Ed.), Ginkgo biloba extract (EGb 761). Elsevier, Paris, pp. 97-142.
11. Drieu K. Préparation et définition de lèxtrait de Ginkgo biloba. Presse. Méd. 15:1986;1455-1457.
12. Erlander M.G., Tobin A.J. The structural and functional heterogeneity of glutamic acid decarboxylase; a review. Neurochem. Res. 16:1991;215-226.
13. Erlander M.G., Tillakaratne N.J.K., Feldblum S., Patel N., Tobin A.J. Two genes encode distinct glutamate decarboxylases. Neuron. 7:1991;91-100.
14. Gale K. GABA in epilepsy: the pharmacological basis. Epilepsia. 30:1989;S1-S11. Suppl. 3.
15. Heffner T.G., Hartman A.J., Seiden L.S. A rapid method for the regional dissection of the rat brain. Pharmacol. Biochem. Behav. 13:1980;453-456.
16. Horton R.W., Chapman A.G., Meldrum B.S. The convulsant action of hydrazides and regional changes in cerebral γ-aminobutyric acid and pyridoxal phosphate concentrations. J. Neurochem. 33:1979;745-749.
17. Houser C.R. GABA neurons in seizure disorders: a review of immunocytochemical studies. Neurochem. Res. 16:1991;295-308.
18. 2-Adrenoceptor changes during cerebral ageing. The effect of Ginkgo biloba extract. J. Pharm. Pharmacol. 44:1992;24-27.
19. 1A receptors during ageing: reversal by Ginkgo biloba extract (EGb 761). J. Pharm. Pharmacol. 46:1994;316-318.
20. Janssens D., Michiels C., Delaive E., Eliaers F., Drieu K., Remacle J. Protection of hypoxia-induced ATP decrease in endothelial cells by Ginkgo biloba extract and bilobalide. Biochem. Pharmacol. 50:1995;991-999.
21. Johansen F.F., Diemer N.H. Enhancement of GABA neurotransmission after cerebral ischemia in the rat reduces loss of hippocampal CA1 pyramidal cells. Acta Neurol. Scand. 84:1991;1-6.
22. Kash S.F., Johnson R.S., Tecott L.H., Noebels J.L., Mayfield R.D., Hanahan D., Baekkeskov S. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase. Proc. Natl. Acad. Sci. U.S.A. 94:1997;14060-14065.
23. Kaufman D.L., Houser C.R., Tobin A.J. Two forms of the γ-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J. Neurochem. 56:1991;720-723.
24. Klein J., Chatterjee S.S., Löffelholz K. Phospholipid breakdown and choline release under hypoxic conditions: inhibition by bilobalide, a constituent of Ginkgo biloba. Brain Res. 755:1997;347-350.
25. Krištofiková Z., Klaschka J. In vitro effect of Ginkgo biloba extract (EGb 761) on the activity of presynaptic cholinergic nerve terminals in rat hippocampus. Dement. Geriatr. Cogn. Disord. 8:1997;43-48.
26. le Bars P.L., Katz M.M., Berman N., Itil T.M., Freedman A.M., Schatzberg A.F. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. J. Am. Med. Assoc. 278:1997;1327-1332.
27. Lindroth P., Mopper K. High performance liquid chromatographic determination of subpicomole amounts of amino acids by precolumn fluorescence derivatization with o-phthaldialdehyde. Anal. Chem. 51:1979;1667-1674.
28. Löscher, W., 1989. GABA and the epilepsies. Experimental and clinical considerations. In: Bowery, N.G., Nisticò, G. (Eds.), GABA, Basic Research and Applications. Pythagora Press, Rome, pp. 260-300.
29. Löscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain. Neurochem. Res. 18:1993;485-502.
30. Löscher W. New visions in the pharmacology of anticonvulsion. Eur. J. Pharmacol. 342:1998;1-13.
31. Lowe I.P., Robins E., Eyerman G.S. The fluorimetric measurement of glutamic decarboxylase and its distribution in brain. J. Neurochem. 3:1958;8-18.
32. Martin D.L., Rimvall K. Regulation of γ-aminobutyric acid synthesis in the brain. J. Neurochem. 60:1993;395-407.
33. McNamara J.O. The neurobiological basis of epilepsy. Trends Neurosci. 10:1992;357-359.
34. Mizuno N., Kawakami K., Morita E. Competitive inhibition between 4′-substituted pyridoxine analogues and pyridoxal for pyridoxal kinase from mouse brain. J. Nutr. Sci. Vitaminol. 26:1980;535-543.
35. Morimoto K., Sato M. NMDA receptor complex and kindling mechanisms. Epilepsy Res. Suppl. 9:1992;297-305.
36. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding system. Anal. Biochem. 107:1980;220-239.
37. Oberpichler H., Beck T., Abdel-Rahman M.M. Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol. Res. Commun. 20:1988;349-368.
38. Otani M., Chatterjee S.S., Gabard B., Kreutzberg G.W. Effects of an extract of Ginkgo biloba on triethyltin-induced cerebral edema. Acta Neuropathol. 69:1986;54-65.
39. Phillips N.I., Fowler L.J. The effects of sodium valproate on γ-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice. Biochem. Pharmacol. 31:1982;2257-2261.
40. 67 protein is highly sensitive to small increases in intraneuronal γ-aminobutyric acid levels. J. Neurochem. 62:1994;1375-1381.
41. Sasaki K., Hatta S., Wada K., Ohshika H., Haga M. Anticonvulsant activity of bilobalide, a sesquiterpene in Ginkgo biloba L. leaves, against chemical-induced and electroshock-induced convulsions in mice. Res. Commun. Biol. Psychol. Psychiatry. 20:1995;145-156.
42. Sasaki K., Wada K., Hatta S., Ohshika H., Haga M. Bilobalide, a constituent of Ginkgo biloba L., potentiates drug-metabolizing enzyme activities in mice: possible mechanism for anticonvulsant activity against 4-O-methylpyridoxine-induced convulsions. Res. Commun. Mol. Pathol. Pharmacol. 96:1997;45-56.
43. Schwartz R.D., Huff R.A., Yu X., Carter M.L., Bishop M. Postischemic diazepam is neuroprotective in the gerbil hippocampus. Brain Res. 647:1994;153-160.
44. Taylor J.E. Liaison des neuromédiateurs à leurs récepteurs dans le cerveau de rats. Effect de l'administration chronique de l'extrait de Ginkgo biloba. Presse Med. 15:1986;1491-1493.
45. A receptor function and cross-tolerance to ethanol in diazepam-dependent rats. Alcohol. Clin. Exp. Res. 20:1996;40A-44A.
46. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:1979;4350-4354.
47. van der Heyden J.A.M., Korf L. Regional levels of GABA in the brain: rapid semiautomated assay and prevention of postmortem increase by 3-mercapto-propionic acid. J. Neurochem. 31:1978;197-203.
48. Wada K., Sasaki K., Miura K., Yagi M., Kubota Y., Matsumoto T., Haga M. Isolation of bilobalide and ginkgolide A from Ginkgo biloba L. shorten the sleeping time induced in mice by anesthetics. Biol. Pharm. Bull. 16:1993;210-212.
49. Zukin S.R., Young A.B., Snyder S.H. Gamma-aminobutyric acid binding to receptor sites in the rat central nervous system. Proc. Natl. Acad. Sci. U.S.A. 71:1974;4802-4807.